Similar Items: Prevalence of Lewy body pathology and phenotypic associations in patients with mild cognitive impairment: Evidence from the Interceptor study
- A potential multimodal biomarker – cognitive signature associated with the conversion from subjective cognitive decline to mild cognitive impairment
- Refining cognitive dispersion metrics for brain–behavior prediction in aging and mild cognitive impairment
- Regional amyloid PET asymmetry and long‐term clinical trajectory in mild cognitive impairment
- A combination of ketones and NAD+ precursor preserves white matter integrity in mild cognitive impairment
- Virtual reality-based cognitive assessment tools for mild cognitive impairment screening: comparison with traditional paper-and-pencil-based cognitive assessment tools
- The utility of a composite endpoint for tracking disease progression in Lewy body dementia